Alimera Sciences Cash from Operations TTM:
-21.18M for Dec. 31, 2012Alimera Sciences Historical Cash from Operations TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -21.18M |
| Sept. 30, 2012 | -19.06M |
| June 30, 2012 | -20.20M |
| March 31, 2012 | -21.14M |
| Dec. 31, 2011 | -20.72M |
| Sept. 30, 2011 | -22.18M |
| June 30, 2011 | -21.84M |
| March 31, 2011 | -22.40M |
| Dec. 31, 2010 | -22.05M |
| Sept. 30, 2010 | -20.75M |
| June 30, 2010 | -19.42M |
| March 31, 2010 | -18.65M |
| Dec. 31, 2009 | -17.54M |
| Sept. 30, 2009 | -21.40M |
| June 30, 2009 | -21.57M |
| March 31, 2009 | -19.64M |
| Dec. 31, 2008 | -32.12M |
About Cash From Operations (TTM)
ALIM Cash from Operations TTM Benchmarks
| Companies | |
|---|---|
| pSivida | -7.384M |
| Ampio Pharmaceuticals | -10.21M |
| Tetraphase Pharmaceuticals |
ALIM Cash from Operations TTM Rankings
| Overall |
39th percentile 4581 of 7593 |
| Sector |
26th percentile 479 of 650 in Healthcare |
| Industry |
36th percentile 33 of 52 in Drug Manufacturers - Major |
ALIM Cash from Operations TTM Range, Past 5 Years
| Minimum | -32.12M | Dec 2008 |
| Maximum | -17.54M | Dec 2009 |
| Average | -21.29M |
